Literature DB >> 9029833

Genotype-phenotype correlation in Duchenne/Becker muscular dystrophy patients seen at Lucknow.

B Mittal1, V Singh, S Mishra, S Sinha, R D Mittal, L S Chaturvedi, S Danda, S Pradhan, S S Agarwal.   

Abstract

The molecular basis of two allelic forms of muscular dystrophy, Duchenne (DMD) and Becker (BMD), has been explained by frame shift hypothesis. In order to test this hypothesis, deletional mutations in 59 patients confirmed to have DMD and 11 BMD patients were analysed using multiplex polymerase chain reaction and Southern hybridization with dystrophin cDNA probes. Translational reading frame of the dystrophin gene was derived from 'Border type' analysis of exons flanking the intragenic deletions. The correlation between genotype (reading frame) and phenotype (clinical severity) showed higher number of DMD patients (approximately 20%) deviating from the frame shift hypothesis. The patients who deviated had deletions at the central hot spot region of the dystrophin gene. The presence of these deviations in a large number of DMD patients highlights the difficulties in predicting the clinical progression of the disease based only on DNA profile.

Entities:  

Mesh:

Year:  1997        PMID: 9029833

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  3 in total

Review 1.  Molecular diagnosis of neurological disorders in India.

Authors:  I C Verma
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

2.  Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy.

Authors:  Gholamreza Zamani; Sareh Hosseinpour; Mahmoud Reza Ashrafi; Mahmoud Mohammadi; Reza Shervin Badv; Ali Reza Tavasoli; Masood Ghahvechi Akbari; Ali Hosseini Bereshneh; Reza Azizi Malamiri; Morteza Heidari
Journal:  BMC Neurol       Date:  2022-05-02       Impact factor: 2.903

Review 3.  Muscular dystrophies.

Authors:  Monisha Mukherjee; Balraj Mittal
Journal:  Indian J Pediatr       Date:  2004-02       Impact factor: 5.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.